HIF1A and hereditary clear cell renal cell carcinoma: Our laboratory had previously demonstrated that the combination of rapamycin and panobinostat resulted in HIF-1α protein degradation associated with a reduction in tumor angiogenesis of prostate and renal cell carcinoma xenograft models [19].